JP2019534883A5 - - Google Patents

Download PDF

Info

Publication number
JP2019534883A5
JP2019534883A5 JP2019519219A JP2019519219A JP2019534883A5 JP 2019534883 A5 JP2019534883 A5 JP 2019534883A5 JP 2019519219 A JP2019519219 A JP 2019519219A JP 2019519219 A JP2019519219 A JP 2019519219A JP 2019534883 A5 JP2019534883 A5 JP 2019534883A5
Authority
JP
Japan
Prior art keywords
acceptable salt
pharmaceutically acceptable
stereoisomer
item
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019519219A
Other languages
English (en)
Japanese (ja)
Other versions
JP7034152B2 (ja
JP2019534883A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/055109 external-priority patent/WO2018067685A1/en
Publication of JP2019534883A publication Critical patent/JP2019534883A/ja
Publication of JP2019534883A5 publication Critical patent/JP2019534883A5/ja
Application granted granted Critical
Publication of JP7034152B2 publication Critical patent/JP7034152B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019519219A 2016-10-05 2017-10-04 小分子ampk活性化剤 Active JP7034152B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662404592P 2016-10-05 2016-10-05
US62/404,592 2016-10-05
PCT/US2017/055109 WO2018067685A1 (en) 2016-10-05 2017-10-04 Small molecule ampk activators

Publications (3)

Publication Number Publication Date
JP2019534883A JP2019534883A (ja) 2019-12-05
JP2019534883A5 true JP2019534883A5 (https=) 2020-11-12
JP7034152B2 JP7034152B2 (ja) 2022-03-11

Family

ID=61832129

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019519219A Active JP7034152B2 (ja) 2016-10-05 2017-10-04 小分子ampk活性化剤

Country Status (8)

Country Link
US (2) US11040935B2 (https=)
EP (1) EP3522877B1 (https=)
JP (1) JP7034152B2 (https=)
KR (1) KR20190096949A (https=)
CN (1) CN110035745B (https=)
AU (1) AU2017340403B2 (https=)
RU (1) RU2766146C2 (https=)
WO (1) WO2018067685A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3522877B1 (en) 2016-10-05 2023-12-06 University of Pittsburgh - Of the Commonwealth System of Higher Education Small molecule ampk activators
AU2020345766A1 (en) 2019-09-10 2022-03-03 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Methods and materials for increasing level of phosphorylated AMPK protein
CN111925345B (zh) * 2020-08-21 2023-09-29 上海科利生物医药有限公司 一种手性2-氨甲基四氢呋喃的制备方法
US20250129093A1 (en) * 2022-02-15 2025-04-24 The Children's Medical Center Corporation Compositions and methods relating to atp/p2x7r signaling inhibition

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2547524A1 (de) * 1975-10-23 1977-04-28 Bayer Ag Disubstituierte phenolaether des 3-amino-2-hydroxypropans, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
JPS5726653A (en) 1980-05-09 1982-02-12 Ciba Geigy Ag Substituted phenyl ether
US4410472A (en) 1982-01-15 1983-10-18 Aluminum Company Of America Method for making spherical binderless pellets
US4552960A (en) 1983-06-20 1985-11-12 Eli Lilly And Company Fungicidal amines
DE4017019A1 (de) 1990-05-26 1991-11-28 Hoechst Ag Verwendung von substituierten ss-hydroxyethylaminen als potente hemmstoffe der exoenzyme von pilzen
TW205034B (https=) * 1990-09-13 1993-05-01 Pola Kasei Kogyo Kk
FI924053A7 (fi) 1991-09-14 1993-03-15 Hoechst Ag Substituoidut aminopropaanit, menetelmä niiden valmistamiseksi ja niiden käyttö
US5541204A (en) 1994-12-02 1996-07-30 Bristol-Myers Squibb Company Aryloxypropanolamine β 3 adrenergic agonists
MXPA01011956A (es) * 1999-05-27 2002-06-21 Dimensional Pharm Inc Oxazaheterociclos como inhibidores de proteasas.
AUPQ841300A0 (en) * 2000-06-27 2000-07-20 Fujisawa Pharmaceutical Co., Ltd. New aminoalcohol derivatives
US6395762B1 (en) * 2000-07-17 2002-05-28 American Home Products Corporation Phenyl amino squarate and thiadiazole dioxide beta-3 adrenergic receptor agonists
US6476016B2 (en) * 2000-07-17 2002-11-05 3-Dimensional Pharmaceuticals, Inc. Cyclic oxyguanidine pyrazinones as protease inhibitors
WO2003024953A1 (en) * 2000-08-10 2003-03-27 Nisshin Pharma Inc. Propanolamine derivative having 1,4-benzodioxane ring
AR035605A1 (es) 2000-12-11 2004-06-16 Bayer Corp Derivados de aminometil cromano di-sustituidos, un metodo para su preparacion, composiciones farmaceuticas y el uso de dichos derivados para la manufactura de medicamentos utiles como agonistas beta-3-adreno-receptores
DE10219542A1 (de) * 2001-06-05 2002-12-12 Merck Patent Gmbh CF2O-verbrückte, axial substituierte Cyclohexan-Derivate
US20030158195A1 (en) 2001-12-21 2003-08-21 Cywin Charles L. 1,6 naphthyridines useful as inhibitors of SYK kinase
EP1575495A4 (en) 2002-03-27 2009-12-02 Smithkline Beecham Corp COMPOUNDS AND METHODS
EP1754483A1 (en) * 2005-08-18 2007-02-21 Merck Sante Use of thienopyridone derivatives as AMPK activators and pharmaceutical compositions containing them
US20090275611A1 (en) * 2006-04-07 2009-11-05 Boehringer Ingelheim International Gmbh Compounds Which Modulate The CB2 Receptor
ITMI20061581A1 (it) * 2006-08-04 2008-02-05 Univ Bari Ligandi del recettore beta-3 adrenergico e loro uso in terapia
WO2008142454A1 (en) * 2007-05-22 2008-11-27 Prosidion Limited Bicyclic aryl and heteroaryl compounds for the treatment of metabolic disorders
US20100029689A1 (en) * 2008-07-02 2010-02-04 Memory Pharmaceuticals Corporation Phosphodiesterase 4 inhibitors
US20100279997A1 (en) 2009-05-04 2010-11-04 Lindsay Burns Barbier Analgesic that binds filamin a
EP2882428B1 (en) 2012-07-13 2019-01-16 Pain Therapeutics, Inc. A method of inhibiting tau phosphorylation
WO2014012054A1 (en) 2012-07-13 2014-01-16 Pain Therapeutics, Inc. Alzheimer's disease assay in a living patent
WO2014144130A2 (en) 2013-03-15 2014-09-18 Als Mountain Llc Pharmaceutical composition comprising an ampk activator and a serotonergic agent and methods of use thereof
US9433604B2 (en) 2013-10-08 2016-09-06 Pain Therapeutics Inc. Method for inhibiting growth of cancer cells
EP3522877B1 (en) 2016-10-05 2023-12-06 University of Pittsburgh - Of the Commonwealth System of Higher Education Small molecule ampk activators

Similar Documents

Publication Publication Date Title
JP2019534883A5 (https=)
JP2016518430A5 (https=)
JP2013508288A5 (https=)
JP2015520143A5 (https=)
JP2011037841A5 (https=)
RU2011102587A (ru) Дизамещенные фенильные соединения
JP2010535722A5 (https=)
JP2015531371A5 (https=)
DE05705627T1 (de) Trägerampholyte mit hohem ph-wert-bereich
JP2015523383A5 (https=)
JP2011137045A5 (https=)
JP2019513770A5 (https=)
JP2016531126A5 (https=)
RU2018110372A (ru) Полоски с хирургическими скобами, допускающие наличие скоб с переменными свойствами и обеспечивающие простую загрузку кассеты
RU2012123154A (ru) Способы лечения синдрома фибромиалгии
ME02754B (me) Ligandi opioidnih receptora i postupci njihove upotrebe i pripreme
JP2015509098A5 (https=)
RU2016118399A (ru) Производные 4-аминометилбензойной кислоты
AR082519A1 (es) Fenilamidinas que tienen alta actividad fungicida, y su utilizacion
RU2015131103A (ru) Синергические фунгицидные смеси для борьбы с грибковыми болезнями злаков
JP2015518821A5 (https=)
RU2015122126A (ru) Производное пиррол сульфонамида, метод его получения и применение в медицине
JP2017521436A5 (https=)
JP2022518741A5 (https=)
RU2017115809A (ru) Комбинированная терапия ингибиторами с-с хемокинового рецептора 9 (ccr9) и антителами, блокирующими альфа4бета7-интегрин